|
|
|
|
| LEADER |
00915naa a2200253 i 4500 |
| 001 |
NSK01000896065 |
| 003 |
HR-ZaNSK |
| 005 |
20150420163214.0 |
| 007 |
ta |
| 008 |
150108s2013 ci | |0|| ||eng |
| 035 |
|
|
|a (HR-ZaNSK)000896065
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 042 |
|
|
|a croatica
|
| 044 |
|
|
|a ci
|c hr
|
| 080 |
1 |
|
|a 615
|2 MRF 2011.
|
| 100 |
1 |
|
|a Ibrahim, Mohamed Abbas
|
| 245 |
1 |
0 |
|a Formulation and evaluation of mefenamic acid sustained release matrix pellets /
|c Mohamed Abbas Ibrahim.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 32 jed.
|
| 653 |
|
0 |
|a Mefenamična kiselina
|a Matrične pelete
|a Reološka svojstva
|a Kontrolirano oslobađanje lijeka
|
| 773 |
0 |
|
|t Acta pharmaceutica (Zagreb)
|x 1330-0075
|g 63 (2013), 1 ; str. 85-98
|
| 981 |
|
|
|b B08/13
|p CRO
|
| 998 |
|
|
|a milo150108
|
| 856 |
4 |
2 |
|u http://hrcak.srce.hr/index.php?show=clanak&id_clanak_jezik=141392
|y Elektronička verzija članka
|